Table 3.
LDX Dose Group | SKAMP-D | SKAMP-A | Quality of Work | Total |
30 mg/d (n = 46) | -0.70 | -0.59 | -0.60 | -0.73 |
(-0.88, -0.52) | (-0.79, -0.40) | (-0.78, -0.42) | (-0.87, -0.59) | |
50 mg/d (n = 47) | -0.68 | -0.61 | -0.67 | -0.74 |
(-0.84, -0.52) | (-0.78, -0.45) | (-0.81, -0.54) | (-0.86, -0.62) | |
70 mg/d (n = 20) | -0.96 | -0.89 | -0.68 | -0.99 |
(-1.30, -0.63) | (-1.15, -0.64) | (-0.94, -0.42) | (-1.24, -0.74) |
LDX: lisdexamfetamine dimesylate; LS: least squares; SKAMP: Swanson, Kotkin, Agler, M-Flynn, and Pelham scale; D: deportment; A: attention; CI: confidence interval
*Negative scores indicate improvement relative to placebo.